MYnd Analytics

Mynd Analytics Summary Financials People Technology Signals & News About Mynd Analytics provides reference data and analytic tools for clinicians and researchers in psychiatry. Acquired by Emmaus Medical Logo Emmaus Medical California City, California, United States 11-50 Post-IPO Debt Public www.MYndAnalytics.com 47,570 Highlights Stock Symbol NASDAQ:MYND Number of Acquisitions 1 Total Funding Amount $6.6M Number of Current Team Members 4 Recent News & Activity Acquisition • Jul 23, 2019 Emmaus Medical acquired Mynd Analytics for an undisclosed amount Discover more acquisitions News • Jul 22, 2019 PRNewswire — Emmaus Life Sciences Receives Notice of Nasdaq Delisting Following Merger with MYnd Analytics News • May 24, 2019 Benzinga — Secondary Offerings Put A Pause On May's Momentum VIEW ALL Details Industries Analytics Clinical Trials Health Care Headquarters Regions West Coast, Western US Founded Date 1987 Operating Status Active Last Funding Type Post-IPO Debt Legal Name CNS Response Stock Symbol NASDAQ:MYND Company Type For Profit Contact Email info@myndanalytics.com Phone Number 888-545-2677 Mynd Analytics, formerly CNS Response, provides reference data and analytic tools for clinicians and researchers in psychiatry. It is a predictive analytics company that aims to improve the delivery of mental health through telemedicine and data analytics. The company mainly focuses on developing a decision support tool to help physicians reducetrial and error treatment in mental health and provide more personalized care to patients.